Efficacy and safety of telotristat etiprate in patients with carcinoid syndrome not adequately controlled by somatostatin analog therapy: analysis of the ongoing TELESTAR extension period.
Hrsch, D Kulke, M Caplin, M Anthony, L Bergsland, E Oberg, K Welin, S Warner, R Lombard-Bohas, C Kunz, P
Hrsch, D
Kulke, M
Caplin, M
Anthony, L
Bergsland, E
Oberg, K
Welin, S
Warner, R
Lombard-Bohas, C
Kunz, P
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Efficacy and Safety of Telotristat Etiprate in Patients with Carcinoid Syndrome Not Adequately Controlled by Somatostatin Analog Therapy: Analysis of the Ongoing TELESTAR extension period. 2016, 103:88-88 Neuroendocrinology